This AI-generated summary is based on the following references:

1. Cornberg M, Sandmann L, Jaroszewicz J, Kennedy P, Lampertico P, Lemoine M, et al. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of Hepatology. 2025 May [DOI: 10.1016/j.jhep.2025.03.018].

This AI-generated summary is based on the following references:

1. Cornberg M, Sandmann L, Jaroszewicz J, Kennedy P, Lampertico P, Lemoine M, et al. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of Hepatology. 2025 May [DOI: 10.1016/j.jhep.2025.03.018]

‌

This AI-generated summary is based on the following references:

1. Gebara NY, El Kamari V, Rizk N. HIV-1 elite controllers: an immunovirological review and clinical perspectives. Journal of Virus Eradication. 2019 Jul;5(3):163–6.

‌2. Khan M, Bradshaw D, Brown CS, Haddow J, Patel P, Tosswill JHC, et al. Characterization of Rare Spontaneous Human Immunodeficiency Virus Viral Controllers Attending a National United Kingdom Clinical Service Using a Combination of Serology and Molecular Diagnostic Assays. Open Forum Infectious Diseases. 2023 Mar 1;10(5).

‌3. Giliauskas D. Considerations for the clinical management of HIV elite controllers – The Ontario HIV Treatment Network. 2018.

‌

An AI-generated discussion based on the following articles:

1. Ismael S, Khan MM, Kumar P, Sunitha Kodidela, Golnoush Mirzahosseini, Kumar S, et al. HIV Associated Risk Factors for Ischemic Stroke and Future Perspectives. International Journal of Molecular Sciences. 2020 Jul 26;21(15):5306–6.

2. Benjamin LA, Bryer A, Emsley HC, Khoo S, Solomon T, Connor MD. HIV infection and stroke: current perspectives and future directions. The Lancet Neurology. 2012 Sep 17;11(10):878–90.

3. Singer EJ, Valdes-Sueiras M, Commins DL, Yong W, Carlson M. HIV stroke risk: evidence and implications. Therapeutic Advances in Chronic Disease. 2013 Jan 7;4(2):61–70.

‌

‌

‌